Affimed N.V. (AFMD) Social Stream
AFFIMED NV (AFMD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AFMD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 5 | $15 | $10 | $12.2 | $0.663 | 1740.12% |
| 2021-11-11 | 5 | $15 | $10 | $12 | $0.663 | 1709.95% |
| 2022-01-12 | 5 | $15 | $11 | $12.4 | $0.663 | 1770.29% |
| 2022-02-23 | 6 | $12 | $11 | $11.8 | $0.663 | 1679.79% |
| 2022-04-01 | 6 | $13 | $7 | $11 | $0.663 | 1559.13% |
| 2022-04-27 | 6 | $13 | $7 | $10.666 | $0.663 | 1508.75% |
| 2022-06-01 | 6 | $13 | $7 | $10.5 | $0.663 | 1483.71% |
| 2022-06-02 | 6 | $12 | $7 | $10.333 | $0.663 | 1458.52% |
| 2022-08-12 | 6 | $12 | $7 | $10 | $0.663 | 1408.3% |
| 2022-08-18 | 7 | $12 | $7 | $9.714 | $0.663 | 1365.16% |
| 2022-10-09 | 7 | $12 | $7 | $9.333 | $0.663 | 1307.69% |
| 2022-10-10 | 7 | $12 | $2 | $8.166 | $0.663 | 1131.67% |
| 2022-11-03 | 7 | $12 | $2 | $8.333 | $0.663 | 1156.86% |
| 2022-11-16 | 7 | $12 | $2 | $8.714 | $0.663 | 1214.33% |
| 2022-12-12 | 8 | $11 | $2 | $7.25 | $0.663 | 993.51% |
| 2023-01-05 | 7 | $11 | $2 | $6.857 | $0.663 | 934.24% |
| 2023-05-24 | 7 | $8.5 | $1 | $6.214 | $0.663 | 837.25% |
| 2023-06-05 | 7 | $8 | $1 | $5.714 | $0.663 | 761.84% |
| 2023-08-10 | 8 | $8 | $1 | $5.75 | $0.663 | 767.27% |
| 2023-08-11 | 8 | $7 | $1 | $5.25 | $0.663 | 691.86% |
| 2023-09-28 | 8 | $7 | $1 | $4.666 | $0.663 | 603.77% |
| 2023-11-15 | 8 | $7 | $1 | $4.5 | $0.663 | 578.73% |
The Trend in the Analyst Price Target
AFMD's average price target has moved down $4.83 over the prior 13 months.
Over the past 33 weeks, AFMD's average upside potential has been 814.81%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-27 | 7 | 8.5 | 1 | 6.214 | 0.689 | 801.89% |
| 2023-06-05 | 7 | 8.0 | 1 | 5.714 | 0.755 | 656.82% |
| 2023-08-08 | 8 | 8.0 | 1 | 5.750 | 0.579 | 893.09% |
| 2023-08-10 | 8 | 8.0 | 1 | 5.750 | 0.543 | 958.93% |
| 2023-08-11 | 8 | 7.0 | 1 | 5.125 | 0.552 | 828.44% |
AFMD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 30 months, AFMD's average broker recommendation rating improved by 0.42.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AFMD as an investment opportunity.
- In terms of how AFFIMED NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 3213.84% of that group.
- To contextualize these metrics, consider that out of all US stocks, AFFIMED NV's average analyst price target is higher than 297.99% of them.
- In the context of stocks in the small market cap category, AFFIMED NV's number of analysts covering the stock is greater than 2551.62% of them.
- In the context of Pharmaceutical Products stocks, AFFIMED NV's variance in analysts' estimates is lower than -1673.34% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AFFIMED NV are SMMT, KALV, and XBIT.
View All Top Stocks by Price Target
What is the outlook for AFMD? Use POWR Ratings for clearer insight into price direction.